Vitamin D3 for Life

Live Enlightened

Article

VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence Review

Previous related pageUnderstanding Vitamin D3Next related pageVDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Study Summary
Study at a glance

How was active vitamin D tested for calcium signals and gene activity?

Researchers used A431 cells, a human cancer-cell line grown in the laboratory. They removed either the vitamin D receptor, called VDR, or another protein called PDIA3. They then added calcitriol, the active vitamin D hormone, and measured rapid calcium-related signals and tested control of gene activity later.

How did removing each protein affect calcium signals and gene activity?

Removing either protein changed the response pattern, but not in one uniform way. Calcium-related signals were especially reduced or altered when PDIA3 was absent. Removing VDR greatly reduced the response to vitamin D in one test of gene activity. Removing PDIA3 did not remove that response and could increase it at early measurements. Results depended on the test and when it was measured.

Did the early calcium signal cause the later gene response?

No. Calcium-related signals were measured within minutes, while responses in gene-activity tests were measured over hours. An earlier signal does not prove it caused the later response. The experiments did not establish whether calcium came from outside the cell or from internal stores. Removing a protein could also change the cells before calcitriol was added, rather than affecting only the immediate response.

Can these cancer-cell findings establish a benefit from supplements?

The study used a cancer-cell model, not normal skin or a whole person. The missing proteins were not restored to test whether each response returned. Repeated samples do not represent independent human donors. Direct exposure to active hormone is different from taking vitamin D3 supplements. The findings support roles for VDR and PDIA3 in this model, but do not establish a clinical benefit, a complete mechanism or an effective supplement dose.

Read the full article below ↓

A study in human A431 carcinoma cells examined how VDR and PDIA3 contribute to responses to active vitamin D. Minute-scale calcium signals and later transcriptional reporters changed after either protein was deleted, but the endpoints did not show one uniform pattern. The companion account is VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Study Summary.

The model and exposure define the question

Nowak and colleagues compared unmodified A431 cells with CRISPR-generated VDR-knockout and PDIA3-knockout cells. A431 is a human epidermoid carcinoma line, not normal human skin. These cells make a controlled comparison possible, but their tumour origin and established culture conditions are part of the result. Receptor biology in this preparation cannot automatically describe a normal keratinocyte, an osteoblast or an intact organ.

The investigators supplied calcitriol, the active metabolite, mostly at 100 nM. That exposure bypasses the conversion steps described in Vitamin D Activation. It tests responses to an added ligand in culture rather than the consequences of oral cholecalciferol, a serum precursor concentration or sunlight exposure. The nominal concentration in a dish also does not specify the free intracellular concentration reaching each candidate binding site.

The deletion comparisons ask whether cellular response machinery matters. They do not reproduce nutritional insufficiency: a person with a lower precursor concentration still has many receptor-dependent and receptor-independent processes intact. Conversely, deleting a multifunctional protein can change the baseline state before the acute exposure begins. The study therefore needs both its untreated comparisons and its responses to stimulation.

Two fluorescence approaches tracked calcium-related responses. Live imaging with Fluo-4 showed a reduction of the signal after calcitriol in the PDIA3-knockout preparation. Plate measurements using Fura-2 showed smaller positive responses across the genotypes, with the smallest response in PDIA3-knockout cells. Those observations support altered calcium handling, but they do not justify saying that both deletions completely abolished every calcium response.

The assays differ in how they collect and summarise fluorescence. The reported Fura-2 plate configuration used a specified excitation and emission setting rather than a calibrated ratiometric determination of absolute calcium concentration. A change in fluorescence should therefore be described as the measured signal, without inventing an absolute intracellular concentration or treating two assay formats as numerically interchangeable.

A rapid intracellular signal also does not identify its source by itself. Calcium could enter from outside the cell, redistribute from intracellular stores, or reflect a combination of processes. Without selective interruption of the proposed route, the experiment does not prove that an observed fluorescence response is exclusively extracellular influx. This distinction gives the findings a precise connection with Vitamin D and Calcium.

Calimycin, used as a calcium-mobilising comparator, also produced genotype-dependent differences. That observation matters because the knockout cells may differ in their general capacity to handle calcium, not only in their recognition of calcitriol. A response to a control stimulus can reveal an altered starting system. It does not, on its own, identify which protein directly binds the ligand or which compartment supplies the calcium.

Later reporter activity should retain its own timescale

The study also used reporters for NFAT-related transcription and vitamin D response element activity. These were measured over hours rather than the minute-scale calcium recordings. NFAT is responsive to calcium-linked regulation, while a vitamin D response element reporter tests a constructed transcriptional response. Their inclusion helps explore a possible relationship between early signals and later regulation without proving that the measured calcium change caused the reporter response.

VDR deletion greatly reduced the vitamin D response element response. PDIA3 deletion retained, and at early measurements could enhance, that reporter activity. The NFAT response also changed in timing: PDIA3 deletion did not simply switch off all NFAT-related activity, and an earlier response was observed. The findings therefore resist a single diagram in which loss of either protein removes every downstream event to the same extent.

The context in Vitamin D and Gene Expression is useful here. A reporter can demonstrate a response under its assay conditions, but it is not a complete inventory of endogenous genes. Nor does an early reporter peak prove a faster physiological benefit. To establish mediation, an experiment would need to interrupt the candidate calcium-dependent step and test whether the later response changes accordingly.

Candidate channels and protein measurements refine the model

TRPV6 abundance and its response to calcitriol were impaired in the PDIA3-knockout cells. TRPV6 is a plausible participant in calcium handling, but this comparison did not selectively remove or restore the channel to establish that it carried the measured acute signal. A protein can change alongside a response without being the only necessary route for that response.

The investigators examined CAMK2A and ERK1/2 signalling measurements at later intervals, including four and twenty-four hours. VDR-deleted cells had lower baseline phosphorylated CAMK2A and higher phosphorylated ERK1/2, while PDIA3 deletion increased baseline total ERK1/2. Subsequent treatment responses differed by genotype. These snapshots should not be relabelled as direct recordings of a minute-scale kinase cascade. Total abundance, phosphorylation and a ratio of phosphorylated to total protein answer related but distinct questions. A ratio can change because its numerator, denominator or both changed.

The report states that no change was observed in the tested phospholipase A2 or PKC-alpha activity measurements, with those activity data not shown. Supplementary protein-abundance panels are not a substitute for the missing activity results. A phospholipase-C-gamma contribution remained unresolved. The study should therefore not be used to claim that it demonstrated every lipid-enzyme and kinase step proposed in other cellular models.

Receptor deletion supports dependence with important limits

VDR and PDIA3 have different cellular roles, and each deletion can affect more than one process. The comparator measurements support their involvement in the observed response pattern, but no reported restoration experiment reintroduced the missing protein to rescue each endpoint. Such a rescue would help separate the intended genetic perturbation from other persistent differences between cell preparations.

The framework in Vitamin D Receptors distinguishes receptor involvement from an exclusive mechanism. A reduced response after deletion does not prove that the deleted protein is the only ligand-binding component, and a retained response does not show that it is irrelevant. The direction and size of the result can depend on the endpoint, timing and compensatory state of the cell.

The displayed calcium-plate and reporter assays used triplicate samples; protein quantification used three independent experiments. Triplicate wells should not be assumed to represent three independent donors or independently derived knockout lines. The authors also considered transcriptomic differences using an earlier dataset. Reanalysis can add context, but it is not a new independent repetition of the acute experiment. Likewise, the final pathway illustration summarises the proposed model; it should not be counted as another experimental demonstration. Each arrow needs to be traced back to the specific measurement that supports it.

Supplementary results constrain dose and pathway claims

The supplementary calcium-fluorescence experiment shows several concentrations, with panels labelled 1 micromolar, 100 nM and 10 nM. The narrative and panel references are not fully consistent about the lower concentrations. The inspected material therefore does not establish a verified 1 nM threshold or a minimum effective physiological dose. Reporting the main 100 nM setting avoids resolving that discrepancy by guesswork.

This is a limitation of a particular dose claim, not a reason to discard every observation. The main genotype comparisons, time courses and displayed calcium measurements can still be discussed at the resolution they support. A careful appraisal separates the result that is visible from a stronger extrapolation that would require clarification or additional experimentation.

The comparison between an acute response and a genetically altered baseline is particularly important here. A knockout is present while the cells grow and organise their membranes, calcium stores and regulatory proteins. The calcitriol exposure is then superimposed on that altered system. An endpoint difference may consequently reflect the immediate absence of a signalling participant, an earlier change in cell physiology, or both. Measuring a response after adding ligand cannot by itself separate those possibilities. This is why the baseline and calimycin comparisons are part of the causal interpretation rather than merely technical controls.

A direct mediation test would also need to preserve the distinction between correlation and temporal order. An early calcium signal occurring before reporter activity makes a causal connection possible, but many parallel responses could occur during the interval. If a selective calcium-pathway intervention removed the reporter response while leaving cell viability and other relevant responses intact, that would strengthen the proposed connection. If the reporter persisted, it would argue for another route or compensation. The current observations motivate those alternatives; they do not choose between all of them.

How the findings fit broader signalling physiology

The study contributes to Vitamin D Signalling Pathways by comparing rapid and later events within one cellular system. Rapid and genomic mechanisms need not be mutually exclusive categories. An early signal could influence later transcription, while a pre-existing transcriptional difference could alter the early response. The present design does not establish the full direction of causation between those levels.

The connection with Vitamin D and Inflammatory Signalling is mechanistic and conditional. NFAT-related activity can participate in broader cellular regulation, but this study did not measure improved immune defence or reduced inflammation in people. Similarly, Vitamin D and Endocrine Crosstalk concerns interactions in an organism that are absent from a single cultured-cell comparison.

A useful follow-up would distinguish channel entry from internal calcium release, restore the deleted proteins and test selective interruption of the proposed calcium-to-transcription connection. Normal primary cells would then help assess transfer beyond the carcinoma model. These questions identify the remaining mechanistic uncertainty without turning the experiment into a recommendation for a particular supplement dose or a clinical treatment.

The same reasoning limits comparison with receptor-dependent genomic studies in other cell types. A transcriptional response disappearing after VDR deletion elsewhere does not disprove every PDIA3-related calcium response here. Conversely, a rapid signal in A431 cells does not demonstrate a VDR-independent transcriptional programme in normal tissues. The relevant comparison is the particular exposure, genetic perturbation, time window and endpoint. Treating all of these as simply a vitamin D effect would conceal the experimental distinctions that make the studies informative.

Conclusion

The evidence supports involvement of VDR and PDIA3 in calcium-related and later reporter responses to calcitriol in A431 cells. The responses were assay-, genotype: and time-dependent. The experiment neither established one complete linear pathway nor demonstrated a human health benefit. Its contribution is a testable cellular account of rapid signalling, with clear boundaries around calcium origin, direct mediation and clinical translation.

Sources and publication details

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells. Nowak JI and colleagues. Cells. 2024;13(1):11; published online 20 December 2023. DOI: 10.3390/cells13010011. PMID: 38201216.

Related reading

Library

The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR‐CYP24A1‐ERRα overexpression correlates with poor prognosis in patients with basal‐like breast cancer

Besides estrogen receptor alpha (ERα), estrogen‐related receptor alpha (ERRα) has also been shown to interfere with the VDR pathway, but its role in the antitumor and transactivation activity of calcitriol is completely unknown in breast cancer (BC).

Original paper ↗Read more →

Original sources

Source

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells

Here, the role of VDR and PDIA3 proteins in membrane response to 1,25(OH)2D3 and calcium signaling was investigated in squamous cell carcinoma A431 cell line with or without the deletion of VDR and PDIA3 genes.

Publication details

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells. Nowak JI and colleagues. Cells. 2024;13(1):11; published online 20 December 2023. DOI: 10.3390/cells13010011. PMID: 38201216.

Read more →